Literature DB >> 8222096

Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology.

N A Chronos1, A H Goodall, D J Wilson, U Sigwart, N P Buller.   

Abstract

BACKGROUND: Thrombotic complications occurring during coronary angiography and percutaneous transluminal coronary angioplasty (PTCA) are relatively frequent and can be influenced by the type of radiographic contrast media used. Low osmolar contrast media (LOCM), both ionic and nonionic, have been considered to be safer than the older high osmolar contrast media (HOCM), causing less haemodynamic and symptomatic side effects. Recently, however, nonionic LOCM have been associated with an increased incidence of thrombotic events, including coronary occlusion and stroke. METHODS AND
RESULTS: The effects of commonly used contrast media on platelets in native blood were investigated using immunolabeling and flow cytometry to detect platelet activation in vitro. A nonionic LOCM (Omnipaque) caused profound platelet degranulation in nearly 80% of platelets compared with 2 to 3% of platelets in the control. Conversely, an ionic HOCM (Urografin) caused only 25% degranulation, whereas an ionic LOCM (Hexabrix) caused no platelet activation and, furthermore, it inhibited the effects of thrombin on platelets. Platelet degranulation, quantified by immunolabeling, was paralleled by release of beta-thromboglobulin and platelet factor 4 from platelet alpha-granules. Blood from patients anticoagulated with heparin and pretreated with standard-dose aspirin in preparation for PTCA showed the same pattern of contrast media-induced platelet activation as normal subjects.
CONCLUSIONS: These results suggest that the type of contrast media used during invasive imaging of the vasculature could have a significant effect on platelets. Platelet degranulation within a PTCA-damaged vessel would be increased by a nonionic contrast medium, releasing procoagulant molecules and platelet-derived growth factors into the damaged vessel lumen, which might contribute to acute thrombosis and the initiation of the restenosis process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222096     DOI: 10.1161/01.cir.88.5.2035

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Effects of iodinated contrast media on blood and endothelium.

Authors:  Peter Aspelin; Fulvio Stacul; Henrik S Thomsen; Sameh K Morcos; Aart J van der Molen
Journal:  Eur Radiol       Date:  2006-01-05       Impact factor: 5.315

2.  Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.

Authors:  Rumi J Jaumdally; Chetan Varma; Robert J MacFadyen; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

3.  Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate.

Authors:  J P Fägerstam; A K Ostberg; A C Eriksson; S-G Fransson; P A Whiss
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

Review 4.  Comparative tolerability of contrast media used for coronary interventions.

Authors:  Enrique Esplugas; Angel Cequier; Joan A Gomez-Hospital; Bruno García Del Blanco; Francisco Jara
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Platelet and Thrombin Activity Following Cardiac Catheterization Despite Treatment with Aspirin.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

6.  Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Authors:  T A Tomsick; L D Foster; D S Liebeskind; M D Hill; J Carrozella; M Goyal; R von Kummer; A M Demchuk; I Dzialowski; V Puetz; T Jovin; H Morales; Y Y Palesch; J Broderick; P Khatri; S D Yeatts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

7.  Influence of ionic and non-ionic radiographic contrast media on leukocyte adhesion molecules.

Authors:  Guy L J Vermeiren; Roel Willems; Marc J Claeys; Chris Vrints; Herman Slegers; Philippe G Jorens
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

8.  Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.

Authors:  Sarah C Starossom; Tatyana Veremeyko; Marina Dukhinova; Amanda W Y Yung; Eugene D Ponomarev
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

9.  Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation.

Authors:  Ilya Sotnikov; Tatyana Veremeyko; Sarah C Starossom; Natalia Barteneva; Howard L Weiner; Eugene D Ponomarev
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.